<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-06-23">June 23, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Julia</forename><surname>Liep</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ergin</forename><surname>Kilic</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hellmuth</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jonas</forename><surname>Busch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Klaus</forename><surname>Jung</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Anja</forename><surname>Rabien</surname></persName>
							<email>anja.rabien@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute for Urologic Research</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Sapporo Medical University</orgName>
								<address>
									<country key="JP">JAPAN</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-06-23">June 23, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">EBABFD4477A875730A00A2EB23B67BC0</idno>
					<idno type="DOI">10.1371/journal.pone.0157801</idno>
					<note type="submission">Received: March 24, 2016 Accepted: June 4, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Due to the poor prognosis for advanced renal cell carcinoma (RCC), there is an urgent need for new therapeutic targets and for prognostic markers to identify high risk tumors.</s><s>Micro-RNAs (miRNAs) are frequently dysregulated in tumors, play a crucial role during carcinogenesis and therefore might be promising new biomarkers.</s><s>In previous studies, we identified miR-141-3p and miR-145-5p to be downregulated in clear cell RCC (ccRCC).</s><s>Our objective was to investigate the functional association of these miRNAs, focusing on the cooperative regulation of new specific targets and their role in ccRCC progression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>The effect of miR-141-3p and miR-145-5p on cell migration was examined by overexpression in 786-O cells.</s><s>New targets of both miRNAs were identified by miRWalk, validated in 786-O and ACHN cells and additionally characterized in ccRCC tissue on mRNA and protein level.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>In functional analysis, a tumor suppressive effect of miR-141-3p and miR-145-5p by decreasing migration and invasion of RCC cells could be shown.</s><s>Furthermore, co-overexpression of the miRNAs seemed to result in an increased inhibition of cell migration.</s><s>Both miRNAs were recognized as post-transcriptional regulators of the targets EAPP, HS6ST2, LOX, TGFB2 and VRK2.</s><s>Additionally, they showed a cooperative effect again as demonstrated by a significantly increased inhibition of HS6ST2 and LOX expression after simultaneous overexpression of both miRNAs.</s><s>In ccRCC tissue, LOX mRNA expression was strongly increased compared to normal tissue, allowing also to distinguish between nonmetastatic and already metastasized primary tumors.</s><s>Finally, in subsequent tissue microarray analysis LOX protein expression showed a prognostic relevance for the overall survival of ccRCC patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Renal cell carcinoma (RCC) is the most common kidney tumor in adults, representing approximately 3% of all malignant tumors in humans <ref type="bibr" target="#b0">[1]</ref>.</s><s>The RCCs comprise a very heterogeneous group of tumors.</s><s>The most common histological subtype is the clear cell renal cell carcinoma (ccRCC) which represents about 70% of all RCC <ref type="bibr" target="#b1">[2]</ref>.</s><s>In general, primary RCC shows no early clinical symptoms and is most often first discovered by routine investigations.</s><s>Approximately 25% of diagnosed RCCs already present metastasis and another 20-30% develop metastasis following surgery <ref type="bibr" target="#b1">[2]</ref>.</s><s>Unfortunately, there is a very poor clinical outcome for patients with metastatic RCC of just 1-2 years overall survival after nephrectomy <ref type="bibr" target="#b2">[3]</ref>.</s><s>Although there is a number of therapeutic options like tyrosine kinase inhibitors and angiogenesis inhibitors <ref type="bibr" target="#b1">[2]</ref>, only an unsatisfactory response rate can be achieved so far.</s><s>In addition to the side effects of systemic therapy, drug resistance of tumors is a major problem that needs to be solved <ref type="bibr" target="#b3">[4]</ref>.</s><s>There is a well-founded hope to use a better insight into molecular patterns in order to ensure an adequate risk stratification.</s><s>This will identify tumors with an increased risk for the transition from a local disease to a tumor generating distant metastasis.</s><s>In addition, there is still an urgent need for new molecular targets to develop specific agents for targeted therapy with fewer side effects.</s></p><p><s>MicroRNAs (miRNA) are small, non-protein coding molecules which play a key role in the regulation of gene expression by post-translational inhibition of their specific target transcripts.</s><s>They are found to be involved in the control of several tumor associated processes like cell proliferation, apoptosis, migration and invasion and to be frequently dysregulated in tumor tissue <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>MiRNAs are extensively studied and discussed as a new class of promising biomarkers for the diagnosis and prognosis of tumors.</s><s>For ccRCC we could already establish a comprehensive miRNA expression profile, in which predominantly downregulated miRNAs were identified, like miR-141-3p and miR-145-5p <ref type="bibr" target="#b6">[7]</ref>.</s><s>Reduced expression of these both miRNAs in ccRCCs was also confirmed by later studies <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s>As we have shown in our previous study that the observed inhibition of miR-141-3p and miR-145-5p in RCC cells is mediated by epigenetic mechanisms <ref type="bibr" target="#b6">[7]</ref>, we focused on the functional role of these miRNAs in RCC, here.</s></p><p><s>Both, miR-141-3p and miR-145-5p are described to be dysregulated and to act as tumor suppressors in various tumor entities.</s><s>MiR-141-3p is a member of the miR-200 family, which is found to be generally involved in tumor progression and especially in the epithelial-mesenchymal transition (EMT) of many tumor entities <ref type="bibr" target="#b12">[13]</ref>.</s><s>Thus, the miR-200 family is mainly involved in processes of migration and invasion.</s><s>The main tumor suppressive function of miR-145-5p seems to be promotion of apoptosis <ref type="bibr" target="#b13">[14]</ref>, but it is also involved in further processes concerning tumor progression and metastasis formation <ref type="bibr" target="#b14">[15]</ref>.</s></p><p><s>The tumor suppressive activity of miRNAs is determined by their specific targets.</s><s>However, there is a complex network of miRNA and target interactions, so that one single miRNA can affect several hundred different targets, and on the other hand one target can be regulated by various miRNAs.</s><s>To investigate the role of miRNAs in tumorigenesis, their individual major targets have to be identified in order to decipher a part of this complex network.</s><s>There are several algorithms available for the prediction of putative targets, which perform target search based on sequence complementarity as well as on sequence conservation and steric and pairing stability <ref type="bibr" target="#b15">[16]</ref>.</s><s>But since the required sensitivity and specificity of these models is too low, a confirmation by experimental analysis is essential.</s><s>In most cases, the effect of one single miRNA toward the expression of its target is just slight.</s><s>However, many miRNAs can inhibit multiple targets of one pathway, whereby this effect can be enhanced.</s><s>Combining miRNAs with the same targets may result in a cooperative effect and therefore in an effective inhibition or stimulation of appropriate targets or mechanisms <ref type="bibr" target="#b16">[17]</ref>.</s><s>It has been described that the regulatory effect of multiple miRNAs on one common target can be significantly enhanced by a combined inhibition <ref type="bibr" target="#b17">[18]</ref>.</s><s>This could also be a new strategy to improve current therapeutic approaches of miRNA-based therapies for RCCs.</s></p><p><s>The aim of our study was to identify new targets regulated by both miR-141-3p and miR-145-5p in ccRCC, in order to obtain a deeper insight into the network and to better understand the role of these miRNAs and their targets in carcinogenesis of ccRCC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and tissue samples</head><p><s>Malignant and adjacent non-malignant tissue was obtained from patients with ccRCC during nephrectomy at the Department of Urology, University Hospital Charité in Berlin.</s><s>All patients provided written informed consent for the use of their tissue in research.</s><s>The study was approved by the ethics committee (EA1/153/07 and EA1/153/12: 'microRNAs as diagnostic and prognostic signatures in urological tumors') and conducted in compliance with the Declaration of Helsinki.</s><s>The tumor samples were classified according to the 2002 TNM classification and the Fuhrman grading system <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>After surgical resection, all tissue samples for RNA expression analysis were frozen in liquid nitrogen and stored at -80°C until RNA extraction.</s><s>Tissue for immunohistochemical analysis was formalin-fixed and paraffin-embedded (FFPE).</s></p><p><s>For quantitative real-time reverse-transcription PCR (RT-qPCR) analysis we used tissue from malignant tumors and the adjacent non-malignant kidney from 27 patients with ccRCC collected between 2005 and 2012.</s></p><p><s>For immunohistochemical analysis of protein expression in RCC, a tissue microarray (TMA) with FFPE tissue, including 322 ccRCC patients nephrectomized between 1993 and 2004 was used <ref type="bibr" target="#b20">[21]</ref>.</s><s>Clinicopathological characteristics for all patients are listed in Table <ref type="table" target="#tab_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA extraction and RT-qPCR</head><p><s>Total RNA including miRNAs was isolated from the collected frozen ccRCC tissue and renal cancer cell lines using the miRNeasy Mini Kit (Qiagen, Hilden, Germany) in accordance to the manufacturer's protocol and as previously described <ref type="bibr" target="#b21">[22]</ref>.</s><s>RNA quantity was determined with a NanoDrop 1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and absorbance ratios of A260/230 and A260/280 were calculated.</s><s>RNA quality was analyzed by the RNA integrity number (RIN) using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) with a RNA 600 Nano Lab Chip.</s><s>For RT-qPCR analyses only samples with RIN above 5 were included.</s></p><p><s>For mRNA quantification, cDNA synthesis was performed using the Transcriptor First Strand cDNA Synthesis Kit (Roche) and PCR was done on the Light Cycler 480 (Roche) using the QuantiTec SYBR Green PCR Kit or Universal Probe Library (UPL) probes (Roche) with the LightCycler 480 Probes Master (Roche).</s><s>Briefly, in a total volume of 20 μl 0.5-1 μg total RNA was reverse transcribed.</s><s>For PCR measurements, 1 μl of cDNA was amplified with 2.5 μM transcript-specific primers (TIB Molbiol, Berlin, Germany) with the respective assay master.</s><s>The reactions for SYBR Green PCR were performed at 95°C for 15 min, followed by 45 cycles with denaturation at 94°C for 15 s, variable primer annealing temperature for 30 s (S1 Table <ref type="table">)</ref> and elongation at 72°C for 30 s.</s><s>For PCR with specific UPL probes (S1 Table <ref type="table">)</ref>, reactions were performed at 95°C for 10 min, followed by 45 cycles with denaturation at 94°C for 10 s, primer annealing at 60°C for 20 s and elongation at 72°C for 1 s.</s></p><p><s>For mature miRNA quantification, the TaqMan MicroRNA primer assays (Life Technologies GmbH, Applied Biosystems, Darmstadt, Germany) (S2 Table <ref type="table">)</ref> were used according to the manufacturer's protocols, the MIQE guidelines <ref type="bibr" target="#b22">[23]</ref> and as previously described <ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s>Briefly, 6.67 ng of total RNA were transcribed into cDNA using TaqMan MicroRNA reverse transcription Kit (Applied Biosystems) and miRNA-specific stem-looped primers in a total volume of 10 μl.</s><s>The relative quantification was performed on the Light Cycler 480 Instrument (Roche Applied Science, Mannheim, Germany) using 1 μl cDNA, 1x TaqMan Universal PCR Master Mix, No AmpErase UNG and miRNA-specific primers in a total volume of 10 μl in accordance to the manufacturer's recommendations.</s></p><p><s>The PCR measurements were done in triplicates, including non-template control and interplate controls in each PCR run.</s><s>PCR data were analyzed by qBase PLUS software (Biogazelle NV, Gent, Belgium).</s><s>For normalization of the miRNA expression data the reference gene combination miR-28, miR-103 and miR-106a was used <ref type="bibr" target="#b21">[22]</ref>.</s><s>For normalization of the mRNA expression data, the reference gene peptidylproline isomerase A (PPIA) was used <ref type="bibr" target="#b24">[25]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>The human RCC cell lines 786-O and ACHN (American Type Culture Collection, Manassas, VA, USA) were used for transfection experiments.</s><s>786-O cells were cultured in RPMI 1640 (Life Technologies GmbH, Invitrogen, Darmstadt, Germany) and ACHN cells were maintained in Eagle's Minimum Essential Medium (Biochrom GmbH, Berlin, Germany) under standard conditions (37°C, 5% CO 2 ).</s><s>All media were supplemented with 10% fetal calf serum (PAA Laboratories, Pasching, Austria) and penicillin/streptomycin (PAA Laboratories).</s><s>The identity of both cancer cell lines was verified by Multiplexion GmbH (Heidelberg, Germany).</s><s>For transfection, cells were seeded into 6-well plates in a final density of 0.8x 10 5 786-O cells or 2x 10 5 ACHN cells per well.</s><s>The next day, the cells were transfected with pre-miRNA precursors (miR-141, miR-145) or negative control pre-miR-NC#1 (NC#1) (Life Technologies GmbH, Ambion, Darmstadt, Germany) (S3 Table) in a final concentration of 30 nM of each miRNA using Lipofectamine2000 transfection agent (Invitrogen).</s><s>After 48 h incubation, cells were lysed and total RNA was extracted.</s><s>Efficiency of transient cell transfection was verified by different control experiments (S1 Fig).</s></p><p><s>To assess the migratory phenotype of 786-O upon miRNA transfection, BD BioCoat TM Tumor Invasion System (BD Biosciences, Heidelberg, Gremany) was used according to the manufacturer's recommendations.</s><s>For this transwell assay we used BD Falcon HTS FluoroBlok 24-multiwell insert plates with a pore size of 8 μm (BD Biosciences).</s><s>Cells were transfected in 6-well plates as described above.</s><s>After 24 h incubation, cells were seeded into uncoated (for migration rate) and matrigel-coated (for invasion rate) 24-multiwell insert plates.</s><s>In the subsequent incubation time of 20 h, cells were able to migrate through the membrane following the serum gradient from medium without serum in the upper chamber into medium with 5% serum in the lower chamber.</s><s>Quantification of migrated/invasive cells was done by 1 h incubation with 4 μg/μl calcein (Invitrogen) in HBSS (Life Technologies GmbH, Gibco, Darmstadt, Germany) and fluorometric detection of stained cells at wavelengths of 485/538 nm (Ex/Em) on the bottom side of the membrane by using the Fluoroskan Ascent plate reader (Thermo Lab Systems, Langenselbold, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In silico prediction of microRNA targets</head><p><s>In silico target search for putative miRNA targets was performed using the miRWalk software (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/)</s><s><ref type="bibr" target="#b25">[26]</ref>.</s><s>We chose genes containing gene regions with the following search criteria: 2000 upstream flanked + 3`UTR and options: longest transcript; min seed length = 7; p-value 0.05.</s><s>For our analysis, we focused on potential targets, which are already described in literature to be involved in cancerogenesis and tumor progression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>mRNA microarray</head><p><s>For mRNA microarray analysis, data of our previously described and analyzed Human Genome U133 Plus 2.0 Arrays (Affymetrix, Santa Clara, CA, USA) microarray were used <ref type="bibr" target="#b26">[27]</ref>.</s><s>The corresponding data are archived under the GEO Accession No. GSE66272 and GSE66271.</s><s>As threshold we used p 0.05 and valid signal in min.</s><s>50% of patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry</head><p><s>Immunohistochemistry was performed on 4 μm tissue slices of a tissue microarray.</s><s>The tissue was deparaffinized with xylene, gradually hydrated and antigens were demasked in a pressure cooker in 0.001 M EDTA buffer.</s><s>Non-specific binding sides were blocked with Protein Block Reagent (Dako Deutschland GmbH, Hamburg, Germany) for 10 min at room temperature (RT).</s><s>LOX rabbit polyclonal antibody was incubated for 1 h at RT (1:50) (Cat.</s><s>No. ab31238, Abcam, Cambridge, MA, USA).</s><s>Afterwards, secondary donkey polyclonal antibody conjugated with alkaline phosphatase (1:500) (Cat.</s><s>No. 711-056-152, Jackson, ImmunoResearch Laboratories, Inc, West Grove, PA, USA) was applied for 30 min at RT.</s><s>For visualization, slides were stained with Fast Red (Sigma-Aldrich, Munich, Germany) and nuclei were counterstained with haemalaun (Dr.</s><s>K. Hollborn &amp; Söhne, Leipzig, Germany).</s><s>Immunohistochemical analysis was performed on a tissue microarray containing 322 ccRCC tissues, each represented by three spots of 1.0 mm diameter.</s><s>LOX staining was examined separately for the apical (LOXa) and cytoplasmic (LOXc) localization each scored as negative (0), moderately positive (1) and highly positive (2) staining by an expert uro-pathologist (EK) as an average for the three spots of the same case.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data analysis and statistics</head><p><s>For statistical analysis of the data, GraphPad Prism 5.04 (GraphPad Software, San Diego, CA, USA) and SPSS 23 (IBM SPSS Statistics Software, Somers, NY, USA) were used.</s><s>Calculations were performed by parametric (Student's t-test) and non-parametric tests for paired (Wilcoxon test) and unpaired (Mann-Whitney test) data.</s><s>Associations were determined by Spearman's rank correlation or Chi-square test.</s><s>Diagnostic impact of parameters was shown in a Receiver Operating Characteristic (ROC) analysis by calculating the area under the curve (AUC) value.</s><s>Survival analysis were performed by Kaplan-Meier analysis using the log rank test.</s><s>In all cases p-values &lt; 0.05 were considered as statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Inhibition of cell migration by miR-141-3p and miR-145-5p in 786-O cells miR-141-3p and miR-145-5p are described to be negative regulators of cell migration and invasion.</s><s>To analyze the effect of the miRNAs in the RCC cell line 786-O, we performed a migration and invasion assay.</s><s>Here, miR-141-3p had a strong inhibitory effect on migration and invasion and also miR-145-5p tended to inhibit both mechanisms (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>Additionally, the combination of both miRNAs seemed to have a slight cooperative effect on migration compared to the single miRNAs.</s><s>Selection of predicted targets for miR-141-3p and miR-145-5p miRWalk predicted 1099 putative targets for miR-141-3p and 947 putative targets for miR-145-5p.</s><s>Since in most cases there was only a slight inhibitory effect of one miRNA, we wanted to identify also targets which might be regulated by both miRNAs.</s><s>Thus, we compared the two lists and obtained 100 targets, predicted to be targets of miR-141-3p as well as of miR-145-5p (S4 Table <ref type="table">)</ref>.</s><s>Focusing on potential targets which were already described to be involved in carcinogenesis, we performed a literature search for these 100 common targets.</s><s>Because of their oncogenic role in tumor-associated pathways, we selected 10 targets, listed in Table <ref type="table" target="#tab_1">2</ref>, for further analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>miR-141-3p and miR-145-5p regulate expression of various predicted targets in RCC cell lines</head><p><s>To analyze if miR-141-3p and miR-145-5p can affect the expression of the predicted targets in renal cancer cells, we overexpressed one or both miRNAs in cell lines 786-O and ACHN.</s><s>The five targets EAPP, HS6ST2, LOX, TGFB2 and VRK2 were downregulated by each of the miRNAs in at least one of the two cell lines (Fig <ref type="figure" target="#fig_3">2</ref>).</s><s>Furthermore, the target NRP2 was regulated by miR-145-5p only and SLC16A3 was regulated by miR-141-3p only.</s><s>The other targets showed no effect.</s></p><p><s>Interestingly, by combined overexpression of miR-141-3p and miR-145-5p we detected a significantly increased reduction of HS6ST2 and LOX expression (Fig <ref type="figure" target="#fig_3">2</ref>).</s><s>HS6ST2 was generally not detectable in the ACHN cell line, but there was a high expression in 786-O cells.</s><s>This strong HS6ST2 expression in 786-O cells was reduced by 30% after miR-141-3p or miR-145-5p overexpression.</s><s>Combination of both miRNAs then even reached a decrease in HS6ST2 expression of more than 50%.</s><s>The miRNA-mediated inhibition of LOX was different in the two cell lines.</s><s>There was just a slight inhibition by miR-141-3p in both cell lines, but in 786-O cells miR-145-5p reduced LOX expression by about 50% and the combined overexpression of miR-141-3p and miR-145-5p reached an additional decrease of LOX expression of more than 60%.</s></p><p><s>A strong decrease was also observed for TGFB2 expression after miR-141-3p overexpression.</s><s>Here, the target expression was reduced by about 50% just by overexpressing one single miRNA.</s></p><p><s>Because of the interesting cooperative effect of miR-141-3p and miR-145-5p in the regulation of HS6ST2 and LOX, these two targets were selected for further investigations in ccRCC</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Target</head><p><s>Character Reference</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EAPP</head><p><s>promoting proliferation <ref type="bibr" target="#b27">[28]</ref> FRMD4 promoting tumor growth and metastasis <ref type="bibr" target="#b28">[29]</ref> HS6ST2 pro-migratory <ref type="bibr" target="#b29">[30]</ref> ITGB3 promoting proliferation and migration <ref type="bibr" target="#b30">[31]</ref> LOX pro-migratory <ref type="bibr" target="#b31">[32]</ref> NRP2 promoting angiogenesis <ref type="bibr" target="#b32">[33]</ref> SLC16A3 anti-apoptotic <ref type="bibr" target="#b33">[34,</ref><ref type="bibr" target="#b34">35]</ref> TGFB2 involved in growth factor signaling <ref type="bibr" target="#b35">[36]</ref> TNFSF4 involved in TNF signaling and tumor immune response <ref type="bibr" target="#b36">[37]</ref> VRK2 anti-apoptotic <ref type="bibr" target="#b37">[38]</ref> doi:10.1371/journal.pone.0157801.t002</s><s>mRNA expression of LOX negatively correlates with miR-141-3p and miR-145-5p expression in renal tissue of patients with ccRCC</s></p><p><s>As previously described, miR-141-3p and miR-145-5p are substantially lower expressed in ccRCC tissue compared to normal renal tissue <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b38">39]</ref>.</s><s>We analyzed the miRNA expression in the non-malignant and malignant renal tissue of our patient cohort.</s><s>Because of the reduced expression of miRNAs, we expected an increased target expression in ccRCC tissue.</s><s>Accordingly, the target LOX showed a significantly enhanced expression in ccRCC vs. non-malignant tissue by 20 fold (Fig <ref type="figure" target="#fig_5">4A</ref>).</s><s>Moreover, LOX expression was significantly higher in tumor tissue of metastatic ccRCCs than in non-metastatic ccRCCs (Fig <ref type="figure" target="#fig_5">4C</ref>).</s><s>These data agree with our microarray expression data revealing a 10 fold higher LOX expression in non-metastatic ccRCC vs. non-malignant tissue and a 16 fold higher LOX expression in metastatic ccRCC vs. non-malignant tissue.</s></p><p><s>In opposition to our assumption, the other investigated target HS6ST2 showed a major decreased expression in ccRCC tissue in all patients (S3 Fig) <ref type="figure">.</ref></s><s>HS6ST2 expression in tumor tissue was about 50 fold lower than in normal tissue without any difference between metastatic and non-metastatic tumors.</s><s>These results could also be confirmed by our microarray data, which also indicated a downregulation of HS6ST2 of almost 50 fold.</s></p><p><s>By comparing the expression in ccRCC as well as non-malignant tissue, we were able to show a strong correlation between the expression of the target LOX with miRNA expression (S4 Fig) <ref type="figure">.</ref></s><s>Here the correlation of LOX to both miRNAs miR-141-3p (r s = -0.757</s><s>ÃÃÃÃ ) and miR-145-5p (r s = -0.367</s><s>ÃÃ ) was negatively directed.</s><s>This confirms the postulated link between reduced expressed miRNAs and the concomitant increased expression of the corresponding targets.</s></p><p><s>To test whether the investigated targets LOX and HS6ST2 and miRNAs miR-141-3p and miR-145-5p were able to discriminate between non-malignant and ccRCC tissue or between non-metastatic and metastatic renal tumors, we performed a ROC analysis.</s><s>As expected from the previous determined expression data, the targets and miRNAs were suitable markers to differentiate between non-malignant and ccRCC tissue (Table <ref type="table">3</ref>).</s><s>However, a differentiation between local ccRCCs and metastatic ccRCCs was only possible using LOX expression.</s><s>Additionally to these diagnostic features, Kaplan-Meier analysis revealed a strong prognostic significance of LOX mRNA expression in ccRCC tissue for the overall survival of patients (Fig <ref type="figure">5</ref>).</s><s>We also classified tumors in those whose LOXa was greater than LOXc (LOXa &gt; LOXc) and those whose LOXa expression was less than or equal to LOXc (LOXa LOXc).</s><s>When comparing the overall survival of patients of these two groups, we observed, that patients with higher LOXa expression (LOXa &gt; LOXc) seemed to have a significant better survival rate than patients with higher or equal LOXc expression (LOXa LOXc) (p = 0.046) (Fig <ref type="figure" target="#fig_9">7</ref>).</s><s>However, the limiting factor of this classification was the low number of cases in the LOXa &gt; LOXc group with only 9 patients.</s><s>Clinically, the subdivision of patients with non-metastatic tumors is of particular importance.</s><s>If metastatic tumors with pN1 and/or M1 were excluded from analyses (all in group LOXa LOXc), the applied LOX expression level still provided a separation with a tendency to significance (p = 0.071).</s><s>In the further comparison of LOX expression with clinicopathological data, an association was only found with Fuhrman grade (p = 0.047) (Table <ref type="table" target="#tab_2">4</ref>).</s><s>Multivariate Cox regression analysis did not find LOX expression as an independent prognostic factor (S5 Table <ref type="table">)</ref>.</s><s>Both, miR-141-3p and miR-145-5p are frequently dysregulated in various tumors.</s><s>While miR-145-5p is solely described to be decreased in tumors, like in cancer of the bladder <ref type="bibr" target="#b39">[40]</ref>, the prostate <ref type="bibr" target="#b40">[41]</ref> and by our previous study and meanwhile by further groups in the kidney <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b14">15]</ref>, the role of miR-141-3p is less obvious.</s><s>In tumors of the prostate <ref type="bibr" target="#b40">[41,</ref><ref type="bibr" target="#b41">42]</ref>, bladder <ref type="bibr" target="#b42">[43]</ref>, ovary <ref type="bibr" target="#b43">[44]</ref> and lung <ref type="bibr" target="#b44">[45]</ref> the expression of miR-141-3p is increased and in contrast breast <ref type="bibr" target="#b45">[46,</ref><ref type="bibr" target="#b46">47]</ref> gastric <ref type="bibr" target="#b47">[48]</ref> tumors show decreased expression.</s><s>Additionally, in renal tumors miR-141-3p and also the other members of miR-200 family are frequently downregulated <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref>.</s><s>As the reduced expression of miR-141-3p and miR-145-5p is also associated with a shorter tumor-specific <ref type="bibr" target="#b10">[11]</ref> or relapse-free survival of ccRCC patients <ref type="bibr" target="#b51">[52]</ref>, they apparently are involved in pathogenesis of ccRCC although their exact role is still not clear.</s><s>It has been described, that both miRNAs have tumor suppressive functions, including the regulation of mechanisms like proliferation, apoptosis, migration and invasion <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b53">54]</ref>.</s><s>Also in RCC cell lines including 786-O and ACHN both miRNAs are shown to have an inhibitory effect on cell proliferation <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b54">55,</ref><ref type="bibr" target="#b55">56]</ref>.</s><s>Additionally, as previously shown <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b55">56]</ref> and confirmed by our data, miR-141-3p and miR-145-5p can also inhibit migration and invasion of renal cancer cells (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>Additionally, we could demonstrate a new, not yet described cooperative function of miR-141-3p and miR-145-5p in the inhibition of cell migration and furthermore a simultaneous and even cooperative regulation of specific oncogenic targets in RCC cell lines (Fig <ref type="figure" target="#fig_3">2</ref>).</s><s>These new targets are already described to be involved in major mechanisms of cancerogenesis like the proliferation promoting targets EAPP and TGFBR2, the anti-apoptotic target VRK2 and the pro-migratory targets HS6ST2 and LOX.</s><s>So far, there is little information about the expression or functional role of these targets in ccRCC development and progression.</s><s>But for TGFBR2 it is known that an enhanced activity of the corresponding TGF-β signaling pathway is widely involved in pathogenesis of ccRCC <ref type="bibr" target="#b35">[36]</ref>.</s><s>Microarray data implicate an upregulation of LOX in ccRCC <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>, which we could confirm in ccRCC tissue by .</s><s>Accordingly, the negatively correlated expression of LOX and miR-141-3p and miR-145-5p is in line with our assumption of decreased tumor suppressive miRNAs and the associated increase of oncogenic targets (S4 Fig) <ref type="figure">.</ref></s><s>As demonstrated here by miR-141-3p and miR-145-5p, the inhibitory outcome of one single miRNA towards target expression can be just minor.</s><s>However, combining miRNAs with the same target or even with functionally similar targets, a cooperative effect and therefore a more effective inhibition of the appropriate mechanism can be achieved <ref type="bibr" target="#b16">[17]</ref> as shown here for the migration of 786-O cells (Fig 1 <ref type="figure">)</ref>.</s><s>A cooperative inhibition of a single target by multiple miRNAs was already described <ref type="bibr" target="#b17">[18]</ref>.</s><s>This is possible, if the 3'UTR region of an mRNA transcript comprises the complementary sequence to the seed sequence of different miRNAs (S2 Fig) <ref type="figure">.</ref></s><s>Hence, for HS6ST2 and LOX we obtained a significant cooperative inhibitory effect in RCC cell lines combining both miRNAs (Fig <ref type="figure" target="#fig_3">2</ref>).</s><s>Such a cooperation of miR-141-3p and miR-145-5p, however, was previously unknown.</s><s>In contrast to our expectations, the heparin sulfate sulfotransferase HS6ST2 was reduced expressed in tissue (S3 Fig) <ref type="figure">.</ref></s><s>Thus, the in silico presumed inhibition of HS6ST2 by the miRNAs, later demonstrated in cellular transfection experiments, could not be confirmed in human tissue.</s><s>But the cooperative inhibitory action of the miRNAs on HS6ST2 might be an important approach in other tumor entities with high HS6ST2 expression like colon <ref type="bibr" target="#b58">[59]</ref> or cartilage cancer <ref type="bibr" target="#b59">[60]</ref>, which however needs to be examined.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tissue microarray analysis of LOX expression in ccRCC tissue</head><p><s>The mRNA expression level, as well as the protein localization of the lysyl oxidase LOX indicate a possible prognostic potential in ccRCC tissue (Figs <ref type="figure" target="#fig_9">4-7</ref>).</s><s>LOX belongs to a family of secreted lysyl oxidases, catalyzing inter-and intramolecular crosslink of collagen and elastin in the extracellular matrix <ref type="bibr" target="#b60">[61]</ref> and therefore, it plays a central role in the formation and maintenance of extracellular matrix and in the regulation of the structure and cohesion of tissue <ref type="bibr" target="#b61">[62]</ref>.</s><s>Additionally to its function in the extracellular matrix, LOX is thought to carry out tasks in the cytoplasm and even in the nucleus, too, like signal transduction and transcriptional gene regulation <ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref>.</s><s>The exact role here, however, still needs to be investigated.</s><s>Recent reports indicate that the cellular localization of LOX protein in tissue of astrocytomas is associated with the malignancy of the tumor <ref type="bibr" target="#b68">[69]</ref>.</s><s>As far as we know, there were no immunohistological analyses of LOX in kidney tissue.</s><s>Our data suggest, that cellular distribution of LOX protein expression in ccRCC tissue also affects the aggressiveness of the tumor (Fig <ref type="figure" target="#fig_9">7</ref>).</s><s>This could be attributed to the different functions depending on the cell compartment.</s><s>Albeit limiting for the validity of these results is the small number of ccRCC cases with LOXa &gt; LOXc.</s></p><p><s>Depending on cell type and transformation status LOX is up-or downregulated in tumors <ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b71">[72]</ref>.</s><s>Correspondingly, LOX is described to act as tumor suppressor or promoter of tumor progression.</s><s>Microarray data implicated an upregulation of LOX in ccRCC <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>, which we could confirm by RT-qPCR (Fig <ref type="figure" target="#fig_5">4</ref>).</s><s>Using a TMA, however, the findings could not be proven on protein level.</s><s>Reasons for this inconsistency might be post-transcriptional mechanisms or the in vivo half-life period of the protein <ref type="bibr" target="#b71">[72]</ref>.</s><s>Additionally, LOX is initially secreted into the extracellular matrix and afterwards partly returned into the cell for its intracellular functions <ref type="bibr" target="#b63">[64]</ref>.</s><s>We assessed apical and cytoplasmatic LOX, but secreted LOX in the blood stream or in extracellular lumen cannot be quantitatively detected in the TMA.</s></p><p><s>LOX seems to be important in a later tumor stage in the transition to metastatic tumors by stiffening the extracellular matrix, reorganization of the cytoskeleton, increasing cell motility <ref type="bibr" target="#b72">[73,</ref><ref type="bibr" target="#b73">74]</ref>, inducing EMT <ref type="bibr" target="#b74">[75,</ref><ref type="bibr" target="#b75">76]</ref>, hypoxia-induced migration <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b76">77]</ref> and angiogenesis <ref type="bibr" target="#b77">[78]</ref>, as well as by setting up pre-metastatic niches <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b78">79]</ref>.</s><s>Accordingly, LOX is highly expressed mainly in invasive tumors <ref type="bibr" target="#b70">[71]</ref> and is probably involved in the transition from localized to metastatic tumors, also in ccRCCs (Fig <ref type="figure" target="#fig_5">4</ref>).</s><s>Therefore, it might represent a promising biomarker for the detection of patients with high risk for metastasis formation or even serve as a target in preventive therapy for these patients, which is already discussed in the literature for tumors in general <ref type="bibr" target="#b79">[80]</ref>.</s><s>But the development of appropriate medications remains still difficult.</s><s>A possible approach to inhibit LOX expression could be demonstrated in the present study.</s><s>As described above, we identified LOX as a new target of miR-141-3p and miR-145-5p.</s><s>A first link between the pro-migratory LOX and miR-145-5p has been described only in cardiovascular diseases <ref type="bibr" target="#b80">[81]</ref>, but to our knowledge, nothing is known about miR-141-3p or miR-145-5p regulation of LOX in tumors.</s><s>Additionally, in RCC cells, both miRNAs acted cooperatively on LOX, so that the combination of miR-141-3p and miR-145-5p achieved a drastic inhibition of LOX (Fig <ref type="figure" target="#fig_3">2</ref>).</s><s>Thus, a miRNA replacement therapy, as it is already used in a phase I study by the company Mirna Therapeutics, Inc. with miR-34 <ref type="bibr" target="#b81">[82]</ref>, would be conceivable and promising.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>Because of the poor prognosis for patients with metastatic RCC, there is still a for new therapeutic strategies as well as for prognostic and diagnostic markers to identify high risk patients.</s><s>Here the network of cooperating dysregulated miRNAs and their specific targets provides various promising starting points for new investigations.</s></p><p><s>The two miRNAs miR-141-3p and miR-145-5p as well as their target LOX have prognostic and diagnostic potential which might lead to new biomarkers.</s><s>However, especially the newly described cooperative effect of tumor suppressive miRNAs might be a promising approach for the treatment of ccRCC.</s><s>The combined application of different miRNAs could generate a greater inhibitory effect with fewer side effects.</s><s>But first of all, an overall understanding of the linked processes is necessary to assess the risks and to develop the best possible strategy.</s><s>In addition, also the other targets found in our study might be interesting subjects for more extensive investigations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1.</s><s>Effect of miRNAs on cell migration and invasion of renal cancer cell line 786-O.</s><s>A) Cell migration and B) cell invasion of miRNA overexpressing 786-O cells were analyzed by a transwell assay.</s><s>Migration/invasion rate is given in relation to negative control (mean ± SEM).</s><s>P-values are given as numbers above bars.</s><s>NC#1 = negative control; n = 3; t-test (one-tailed).</s><s>doi:10.1371/journal.pone.0157801.g001</s></p></div></figDesc><graphic coords="6,127.90,399.52,448.04,264.70" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>tissue.</s><s>Both targets contain one or two binding sides for miR-141-3p and miR-145-5p in different regions of the 3'UTR of their transcripts (S2 Fig).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Fig 3 shows a decreased expression of both miRNAs.</s><s>MiR-141-3p was reduced in malignant tissue by 19 fold (Fig 3A).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Effect of miRNA overexpression on target expression.</s><s>MiR-141-3p and/or miR-145-5p were overexpressed in renal cancer cell lines 786-O and ACHN for 48 h.</s><s>Effect on mRNA expression of putative targets, which were predicted to be regulated by miR-141-3p and miR-145-5p, was determined by RT-qPCR.</s><s>Data are shown as mean (± SEM) relative to NC#1.</s><s>NC#1 = negative control, n = 3, student's t-test (two-tailed); *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001; ns = not significant.</s><s>doi:10.1371/journal.pone.0157801.g002</s></p></div></figDesc><graphic coords="8,36.00,78.01,540.00,432.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Expression of miR-141-3p and miR-145-5p in ccRCC tissue.</s><s>Expression of miR-141-3p and miR-145-5p in malignant (ccRCC) and non-malignant (N) renal tissue of 27 ccRCC patients was measured by RT-qPCR.</s><s>A) and B) show expression differences between paired normal and ccRCC samples.</s><s>In C) ccRCC tumors are split into non-metastatic (ccRCC-M0; n = 15) and metastatic tumors (ccRCC-M1, n = 12).</s><s>P-values are given as numbers above bars.</s><s>Paired samples: Wilcoxon test; unpaired samples: Mann-Whitney test.</s><s>doi:10.1371/journal.pone.0157801.g003</s></p></div></figDesc><graphic coords="9,75.35,71.38,500.60,487.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Expression of the target LOX in ccRCC tissue.</s><s>Expression of LOX in malignant (ccRCC) and non-malignant (N) renal tissue of 27 ccRCC patients was measured by RT-qPCR.</s><s>A) and B) show expression differences between paired normal and ccRCC samples.</s><s>In C) ccRCC tumors are split into non-metastatic (ccRCC-M0; n = 15) and metastatic tumors (ccRCC-M1, n = 12).</s><s>P-values are given as numbers above bars.</s><s>Paired samples: Wilcoxon test; unpaired samples: Mann-Whitney test.</s><s>doi:10.1371/journal.pone.0157801.g004</s></p></div></figDesc><graphic coords="10,111.35,78.01,464.60,239.98" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><label></label><figDesc><div><p><s>On mRNA level, LOX expression was significantly increased in ccRCC tissues and correlated with decreased miR-141-3p and miR-145-5p expression.</s><s>To assess the relevance of LOX protein expression, we evaluated immunostaining on a tissue microarray containing 322 ccRCC tissues.</s><s>Initially, by analyzing the relation of overall survival after nephrectomy to pathological variables pT and Fuhrman grade (S5 Fig),we could show, that this cohort was representative to analyze the significance of parameters regarding the clinical endpoint 'overall survival'.LOX staining was observed in the cytoplasm, on the apical cell membrane and also in intercellular spaces.</s><s>The assessment of the staining in tumor tissue was performed separately for the apical (LOXa) and cytoplasmic (LOXc) localization with each negative, moderately positive</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Table 3 .Fig 5 .</head><label>35</label><figDesc><div><p><s>Fig 5. LOX mRNA expression is a prognostic marker in ccRCC.</s><s>Kaplan-Meier analysis shows LOX mRNA expression in ccRCC tissue connected with overall survival of patients after nephrectomy.</s><s>Higher LOX expression was significantly associated with a decrease in overall survival.</s><s>Log rank test.</s><s>doi:10.1371/journal.pone.0157801.g005</s></p></div></figDesc><graphic coords="11,200.01,467.94,252.00,196.27" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig 6 .</head><label>6</label><figDesc><div><p><s>Fig 6.</s><s>LOX expression in tissue of ccRCC.</s><s>Apical and cytoplasmic staining were separately scaled in negative, moderately positive or highly positive.</s><s>There was no tumor with high apical and negative cytoplasmic staining.</s><s>Magnification: 200x.</s><s>doi:10.1371/journal.pone.0157801.g006</s></p></div></figDesc><graphic coords="12,98.65,78.01,477.35,359.26" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig 7 .</head><label>7</label><figDesc><div><p><s>Fig 7. LOX expression pattern seems to be a prognostic marker in ccRCC.</s><s>Kaplan-Meier analysis shows LOX staining pattern connected with overall survival of the patients after nephrectomy.</s><s>Higher apical than cytoplasmic LOX staining was significantly associated with an increase in overall survival.</s><s>Log rank test.</s><s>doi:10.1371/journal.pone.0157801.g007</s></p></div></figDesc><graphic coords="13,200.01,78.01,331.43,323.49" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head></head><label></label><figDesc><div><p><s>S1 Fig. Transient cell transfection with miRNAs.</s><s>Efficiency of transient cell transfection was verified by different control experiments.</s><s>A) shows the transfection of 786-O cells with fluorescent labeled miRNA (FAM-labeled Pre-miR Negative Control #1; Life Technologies GmbH, Ambion, Darmstadt, Germany).</s><s>After transfection FAM-labeled miR was localized in the cytoplasm.</s><s>B) shows strongly increased miR-145-5p level in 786-O cells 48 h after transfection detected by RT-qPCR.</s><s>C) To verify the functional activity of transfected miRNA, the direct target of miR-141-3p, ZEB2 and the downstream target CDH1 were detected 48 h after transfection using RT-qPCR.</s><s>Data are shown as mean (± SEM) relative to NC#1.</s><s>NC#1 = negative control, n = 3, student's t-test (two-tailed).</s><s>(PDF) S2 Fig. Predicted binding sites on target transcripts.</s><s>Graphs were generated by TargetScan prediction tool.</s><s>LOX: miR-141-3p (236-242) miR-145-5p (156-162; 827-834) HS6ST2: miR-141-3p (155-162; 1802-1808) miR-145-5p (787-793; 1645-1651) (PDF) S3 Fig. Expression of the target HS6ST2 in ccRCC tissue.</s><s>Expression of HS6ST2 in malignant (ccRCC) and non-malignant (N) renal tissue of 27 ccRCC patients was measured by RT-qPCR.</s><s>A) and B) show expression differences between paired normal and ccRCC samples.</s><s>In C) ccRCC tumors are split into non-metastatic (ccRCC-M0; n = 15) and metastatic tumors (ccRCC-M1, n = 12).</s><s>P-values are given as numbers above bars.</s><s>Paired samples: Wilcoxon test; unpaired samples: Mann-Whitney test.</s><s>(PDF) S4 Fig. Correlation of expression between miRNAs miR-141-3p and miR-145-5p and targets HS6ST2 and LOX.</s><s>Correlation between miRNA and target expression in non-malignant and malignant renal tissue of ccRCC patients.</s><s>r s = Spearman rank correlation coefficients.</s><s>(PDF) S5 Fig. Kaplan-Meier analysis of overall survival of ccRCC patients after nephrectomy depending on clinicopathological markers.</s><s>Log rank test.</s><s>(PDF) S6 Fig. Kaplan-Meier analysis of overall survival of ccRCC patients after nephrectomy depending on LOX expression.</s><s>Log rank test.</s><s>(PDF) S1</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Clinicopathological patient characteristics.</s></p></div></figDesc><table><row><cell>Age in years</cell></row></table><note><p><s>ccRCC patients (n = 27) ccRCC patients (n = 322) mean (range) doi:10.1371/journal.pone.0157801.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Predicted cancer targets of miR-141-3p and miR-145-5p by miRWalk.</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>LOX protein expression pattern in ccRCC.</s></p></div></figDesc><table><row><cell></cell><cell>ccRCC (n = 301)</cell><cell>Chi-square test</cell></row><row><cell>n</cell><cell>LOX a &gt; LOX z (%)</cell><cell>LOX a LOX z (%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc><div><p><s>Table. Assay information for RT-qPCR.</s><s>(PDF) S2 Table.</s><s>Assay information for RT-qPCR.</s><s>S4 Table.</s><s>Predicted targets for miR-141-3p and miR-145-5p.</s><s>(PDF) S5 Table.</s><s>Univariate und multivariate Cox regression for ccRCC patients (pN0M0 only) (n = 284).</s><s>(PDF)</s></p></div></figDesc><table><row><cell>(PDF)</cell></row><row><cell>S3 Table. Synthetic miRNAs.</cell></row><row><cell>(PDF)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0157801 June 23, 2016</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>Conceived and designed the experiments: JL KJ.</s><s>Performed the experiments: JL.</s><s>Analyzed the data: JL EK HAM.</s><s>Contributed reagents/materials/analysis tools: JB.</s><s>Wrote the paper: JL KJ AR.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Patard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pignot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Escudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bex</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sternberg</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2011.06.017</idno>
		<idno type="PMID">21704448</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="684" to="690" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Renal cell carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><surname>Jonasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Rathmell</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.g4797</idno>
		<idno type="PMID">25385470</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page">4797</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kabbinavar</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.critrevonc.2015.07.009</idno>
		<idno type="PMID">26299335</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Rev Oncol Hematol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="527" to="533" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Van Der Mijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Mier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Broxterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Verheul</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drup.2014.10.003</idno>
		<idno type="PMID">25457974</idno>
	</analytic>
	<monogr>
		<title level="j">Drug Resist Updat</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="77" to="88" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">MicroRNAs as regulators of signal transduction in urological tumors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Yousef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2010.157727</idno>
		<idno type="PMID">21632885</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="954" to="968" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">MicroRNAs as new diagnostic and prognostic biomarkers in urological tumors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jung</surname></persName>
		</author>
		<idno type="PMID">23614616</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Rev Oncog</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="289" to="302" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Disch</surname></persName>
		</author>
		<idno type="DOI">10.7150/ijbs.5106</idno>
		<idno type="PMID">23139634</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Biol Sci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1363" to="1374" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients</title>
		<author>
			<persName><forename type="first">K</forename><surname>Doberstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Steinmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Hartmetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Eberhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mittelbronn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Harter</surname></persName>
		</author>
		<idno type="PMID">23441135</idno>
	</analytic>
	<monogr>
		<title level="j">Neoplasia</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="218" to="230" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Enokida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Itesako</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tatarano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kinoshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fuse</surname></persName>
		</author>
		<idno type="DOI">10.1038/jhg.2013.31</idno>
		<idno type="PMID">23635949</idno>
	</analytic>
	<monogr>
		<title level="j">J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="508" to="516" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Papadopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Petraki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gregorakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Fragoulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scorilas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Chem</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep10272</idno>
		<idno type="PMID">25974855</idno>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">10272</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zaravinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Lambrou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mourmouras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Katafygiotis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Papagregoriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Giannikou</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0091646</idno>
		<idno type="PMID">24621579</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e91646</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The role of the miR-200 family in epithelial-mesenchymal transition</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Mongroo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Rustgi</surname></persName>
		</author>
		<idno type="PMID">20592490</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Biol Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="219" to="222" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Ostenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bramsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Villadsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fristrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Sorensen</surname></persName>
		</author>
		<idno type="DOI">10.1038/onc.2009.395</idno>
		<idno type="PMID">19915607</idno>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1073" to="1084" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ji</forename><forename type="middle">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename></persName>
		</author>
		<idno type="DOI">10.1007/s00432-013-1577-z</idno>
		<idno type="PMID">24384875</idno>
	</analytic>
	<monogr>
		<title level="j">J Cancer Res Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="387" to="397" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Online resources for miRNA analysis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Vlachos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Hatzigeorgiou</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clinbiochem.2013.03.006</idno>
		<idno type="PMID">23518312</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Biochem</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="879" to="900" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Au</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Wong</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11684-015-0409-8</idno>
		<idno type="PMID">26293610</idno>
	</analytic>
	<monogr>
		<title level="j">Front Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="331" to="343" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">25909221</idno>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="13149" to="13163" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Prognostic significance of morphologic parameters in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Fuhrman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Lasky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Limas</surname></persName>
		</author>
		<idno type="PMID">7180965</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="655" to="663" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">TNM residual tumor classification revisited</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wittekind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Compton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Sobin</surname></persName>
		</author>
		<idno type="PMID">12015777</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="2511" to="2516" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rabien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kilic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Weichert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kristiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1186/1479-5876-11-258</idno>
		<idno type="PMID">24131772</idno>
	</analytic>
	<monogr>
		<title level="j">J Transl Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">258</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ab.2011.06.009</idno>
		<idno type="PMID">21741950</idno>
	</analytic>
	<monogr>
		<title level="j">Anal Biochem</title>
		<imprint>
			<biblScope unit="volume">417</biblScope>
			<biblScope unit="page" from="233" to="241" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Bustin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Benes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Garson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hellemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huggett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kubista</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2008.112797</idno>
		<idno type="PMID">19246619</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="611" to="622" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Robust microRNA stability in degraded RNA preparations from human tissue and cell samples</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kempkensteffen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Erbersdobler</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2009.141580</idno>
		<idno type="PMID">20378769</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="998" to="1006" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ramankulov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roigas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johannsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ringsdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kristiansen</surname></persName>
		</author>
		<idno type="PMID">17559644</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Mol Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">47</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">miRWalk-database: prediction of possible miRNA binding sites by &quot;walking&quot; the genes of three genomes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Dweep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sticht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gretz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jbi.2011.05.002</idno>
		<idno type="PMID">21605702</idno>
	</analytic>
	<monogr>
		<title level="j">J Biomed Inform</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="839" to="847" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wotschofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gummlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kilic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0148746</idno>
		<idno type="PMID">26859141</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">e0148746</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">EAPP, a novel E2F binding protein that modulates E2F-dependent transcription</title>
		<author>
			<persName><forename type="first">M</forename><surname>Novy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Andorfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Novy-Weiland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Galos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schwarzmayr</surname></persName>
		</author>
		<idno type="PMID">15716352</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Biol Cell</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="2181" to="2190" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Goldie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Mulder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Watt</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-12-0423</idno>
		<idno type="PMID">22564525</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="3424" to="3436" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling</title>
		<author>
			<persName><forename type="first">K</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">B</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1042/BJ20110297</idno>
		<idno type="PMID">21443520</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">436</biblScope>
			<biblScope unit="page" from="271" to="282" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of nonsmall-cell lung cancer</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.2147/OTT.S90998</idno>
		<idno type="PMID">26445551</idno>
	</analytic>
	<monogr>
		<title level="j">Onco Targets Ther</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2689" to="2697" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Lysyl oxidase is essential for hypoxia-induced metastasis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Erler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Bennewith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nicolau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dornhofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">T</forename><surname>Le</surname></persName>
		</author>
		<idno type="PMID">16642001</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">440</biblScope>
			<biblScope unit="page" from="1222" to="1226" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial alpha5 integrin</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Hoeppner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E G</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-13-0529</idno>
		<idno type="PMID">23689123</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="4579" to="4590" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kikukawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Endo</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40164-015-0008-z</idno>
		<idno type="PMID">25909034</idno>
	</analytic>
	<monogr>
		<title level="j">Exp Hematol Oncol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Expression of lactate/H(+) symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.humpath.2014.09.013</idno>
		<idno type="PMID">25456395</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="104" to="112" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Effects of TGF-beta signaling in clear cell renal cell carcinoma cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Bostrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lindgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Axelson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2013.04.054</idno>
		<idno type="PMID">23618868</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">435</biblScope>
			<biblScope unit="page" from="126" to="133" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Anti-tumour therapeutic efficacy of OX40L in murine tumour model</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lynam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Entwisle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Loudon</surname></persName>
		</author>
		<idno type="PMID">15315837</idno>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="3585" to="3594" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Monsalve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Merced</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">F</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vazquez-Cedeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Lazo</surname></persName>
		</author>
		<idno type="DOI">10.1038/cddis.2013.40</idno>
		<idno type="PMID">23449449</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e513</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">MicroRNA profiles classify papillary renal cell carcinoma subtypes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Theil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hartmann</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2013.313</idno>
		<idno type="PMID">23799849</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="714" to="722" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ratert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lioudmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Mollenkopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmoldx.2013.05.008</idno>
		<idno type="PMID">23945108</idno>
	</analytic>
	<monogr>
		<title level="j">J Mol Diagn</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="695" to="705" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Mollenkopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jentzmik</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.24827</idno>
		<idno type="PMID">19676045</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="1166" to="1176" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Androgen regulation of micro-RNAs in prostate cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Waltering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Porkka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Jalava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Urbanucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Kohonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Latonen</surname></persName>
		</author>
		<idno type="DOI">10.1002/pros.21276</idno>
		<idno type="PMID">20945501</idno>
	</analytic>
	<monogr>
		<title level="j">Prostate</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="604" to="614" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">MicroRNA expression signatures of bladder cancer revealed by deep sequencing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sun</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0018286</idno>
		<idno type="PMID">21464941</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e18286</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gadducci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sergiampietri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lanfredini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Guiggi</surname></persName>
		</author>
		<idno type="DOI">10.3109/09513590.2013.871525</idno>
		<idno type="PMID">24479883</idno>
	</analytic>
	<monogr>
		<title level="j">Gynecol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="266" to="271" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tejero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Campayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vinolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Marrades</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cordeiro</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0101899</idno>
		<idno type="PMID">25003366</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e101899</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Harvel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1186/1479-5876-11-57</idno>
		<idno type="PMID">23497265</idno>
	</analytic>
	<monogr>
		<title level="j">J Transl Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">57</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Transl Oncol</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Expression and clinical significance of the microRNA-200 family in gastric cancer</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Huo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<idno type="PMID">26137064</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="2317" to="2324" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nakada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsuura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tsukamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tanigawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Narimatsu</surname></persName>
		</author>
		<idno type="DOI">10.1002/path.2437</idno>
		<idno type="PMID">18925646</idno>
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="418" to="427" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Silva-Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Costa-Pinheiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Antunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Oliveira</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2013.552</idno>
		<idno type="PMID">24129247</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="2646" to="2653" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney</title>
		<author>
			<persName><forename type="first">G</forename><surname>Duns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Den Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Van Dijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van D I, Giezen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kluiver</surname></persName>
		</author>
		<idno type="DOI">10.1002/gcc.22016</idno>
		<idno>PMID:</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="165" to="173" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients</title>
		<author>
			<persName><forename type="first">O</forename><surname>Slaby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Redova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Poprach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nekvindova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Iliev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Radova</surname></persName>
		</author>
		<idno type="DOI">10.1002/gcc.21957</idno>
		<idno type="PMID">22492545</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="707" to="716" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Chiyomaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fukuhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Majid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Shahryari</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M113.488593</idno>
		<idno type="PMID">24616104</idno>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="12550" to="12565" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Seki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kikkawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fujimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hoshino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Akutsu</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.25284</idno>
		<idno type="PMID">21351259</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="2804" to="2814" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression</title>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ruan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-13-3224</idno>
		<idno type="PMID">24647573</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2617" to="2630" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Tumor-suppressive micro-RNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Enokida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Itesako</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kinoshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tatarano</surname></persName>
		</author>
		<idno type="DOI">10.1111/cas.12280</idno>
		<idno type="PMID">24033605</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Sci</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="1567" to="1574" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Rhodes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Furge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kanayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Haab</surname></persName>
		</author>
		<idno type="PMID">11493696</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="9754" to="9759" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Petros</surname></persName>
		</author>
		<idno type="PMID">11337362</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1639" to="1651" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Overexpression of heparan sulfate 6-sulfotransferase-2 in colorectal cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hatabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Arao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nagai</surname></persName>
		</author>
		<idno type="PMID">24649258</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="845" to="850" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Waaijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>De Andrea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hamilton</forename><forename type="middle">A</forename><surname>Van Oosterwijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Stringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bovee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename></persName>
		</author>
		<idno type="DOI">10.1007/s00428-012-1300-5</idno>
		<idno type="PMID">22903264</idno>
	</analytic>
	<monogr>
		<title level="j">Virchows Arch</title>
		<imprint>
			<biblScope unit="volume">461</biblScope>
			<biblScope unit="page" from="475" to="481" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Lysyl oxidase: an oxidative enzyme and effector of cell function</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Lucero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kagan</surname></persName>
		</author>
		<idno type="PMID">16909208</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Mol Life Sci</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2304" to="2316" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">The potential for targeting extracellular LOX proteins in human malignancy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mayorca-Guiliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Erler</surname></persName>
		</author>
		<idno type="DOI">10.2147/OTT.S38110</idno>
		<idno type="PMID">24348049</idno>
	</analytic>
	<monogr>
		<title level="j">Onco Targets Ther</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1729" to="1735" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Intracellular localization of the matrix enzyme lysyl oxidase in polarized epithelial cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Csiszar</surname></persName>
		</author>
		<idno type="PMID">17074474</idno>
	</analytic>
	<monogr>
		<title level="j">Matrix Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="136" to="139" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<idno type="PMID">12577300</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="660" to="672" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nellaiappan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Risitano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nicklas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kagan</surname></persName>
		</author>
		<idno type="PMID">10996848</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="576" to="582" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved</title>
		<author>
			<persName><forename type="first">M</forename><surname>Giampuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Oleggini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Di</surname></persName>
		</author>
		<idno type="PMID">12686141</idno>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1647</biblScope>
			<biblScope unit="page" from="245" to="251" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Lysyl oxidase oxidizes basic fibroblast growth factor and inactivates its mitogenic potential</title>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nugent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Chau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Chou</surname></persName>
		</author>
		<idno type="PMID">12461785</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="152" to="164" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Contente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Planding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schenck</surname></persName>
		</author>
		<idno type="PMID">7556446</idno>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="page" from="374" to="382" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">LOX expression and functional analysis in astrocytomas and impact of IDH1 mutation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Uno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Marie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Oba-Shinjo</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0119781</idno>
		<idno type="PMID">25790191</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0119781</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kaneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wakazono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsukamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tatematsu</surname></persName>
		</author>
		<idno type="PMID">15374948</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="6410" to="6415" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">A molecular role for lysyl oxidase in breast cancer invasion</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Kirschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Seftor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Nieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Edwards</surname></persName>
		</author>
		<idno type="PMID">12154058</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="4478" to="4483" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Paradoxical roles for lysyl oxidases in cancer-a prospect</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Hendrix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Kirschmann</surname></persName>
		</author>
		<idno type="PMID">17471532</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="1338" to="1354" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fogelgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Seftor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Wiley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Fong</surname></persName>
		</author>
		<idno type="PMID">16357151</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="11429" to="11436" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Hendrix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Kirschmann</surname></persName>
		</author>
		<idno type="PMID">16440329</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="827" to="837" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shrimanker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Akai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hohenstein</surname></persName>
		</author>
		<idno type="PMID">18037992</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="3810" to="3820" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1</title>
		<author>
			<persName><forename type="first">R</forename><surname>Schietke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Warnecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schodel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Mole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Campean</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M109.042424</idno>
		<idno type="PMID">20026874</idno>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="6658" to="6669" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Lysyl oxidase in cancer research</title>
		<author>
			<persName><forename type="first">L</forename><surname>Perryman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Erler</surname></persName>
		</author>
		<idno type="DOI">10.2217/fon.14.39</idno>
		<idno type="PMID">25145437</idno>
	</analytic>
	<monogr>
		<title level="j">Future Oncol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1709" to="1717" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Welti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gourlaouen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Murray</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-12-2447</idno>
		<idno type="PMID">23188504</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="583" to="594" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Rumney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Schoof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Perryman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Hoye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Agrawal</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature14492</idno>
		<idno type="PMID">26017313</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">522</biblScope>
			<biblScope unit="page" from="106" to="110" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">The rationale for targeting the LOX family in cancer</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Erler</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc3319</idno>
		<idno type="PMID">22810810</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="540" to="552" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kothapalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Monslow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Hawthorne</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.celrep.2012.09.018</idno>
		<idno type="PMID">23103162</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1259" to="1271" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">miR-34-a microRNA replacement therapy is headed to the clinic</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Bader</surname></persName>
		</author>
		<idno type="DOI">10.3389/fgene.2012.00120</idno>
		<idno type="PMID">22783274</idno>
	</analytic>
	<monogr>
		<title level="j">Front Genet</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">120</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
